FMO2
Basic information
Region (hg38): 1:171185249-171212686
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (58 variants)
- not_provided (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FMO2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001460.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 58 | 61 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 58 | 5 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| FMO2 | protein_coding | protein_coding | ENST00000441535 | 8 | 27476 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.14e-7 | 0.783 | 111898 | 842 | 13007 | 125747 | 0.0567 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.0993 | 256 | 261 | 0.983 | 0.0000136 | 3111 |
| Missense in Polyphen | 86 | 98.658 | 0.8717 | 1233 | ||
| Synonymous | 0.567 | 85 | 91.9 | 0.925 | 0.00000486 | 876 |
| Loss of Function | 1.36 | 13 | 19.5 | 0.667 | 9.05e-7 | 260 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.323 | 0.324 |
| Ashkenazi Jewish | 0.0896 | 0.0901 |
| East Asian | 0.000872 | 0.000870 |
| Finnish | 0.0240 | 0.0237 |
| European (Non-Finnish) | 0.0481 | 0.0478 |
| Middle Eastern | 0.000872 | 0.000870 |
| South Asian | 0.0533 | 0.0528 |
| Other | 0.0530 | 0.0525 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the N-oxidation of certain primary alkylamines to their oximes via an N-hydroxylamine intermediate. Inactive toward certain tertiary amines, such as imipramine or chloropromazine. Can catalyze the S-oxidation of methimazole. The truncated form is catalytically inactive. {ECO:0000269|PubMed:9804831}.;
- Pathway
- Drug metabolism - cytochrome P450 - Homo sapiens (human);Busulfan Pathway, Pharmacodynamics;Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs);Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;FMO oxidises nucleophiles;Biological oxidations;Metabolism;Selenoamino acid metabolism;nicotine degradation IV
(Consensus)
Intolerance Scores
- loftool
- 0.941
- rvis_EVS
- 2.47
- rvis_percentile_EVS
- 98.61
Haploinsufficiency Scores
- pHI
- 0.116
- hipred
- N
- hipred_score
- 0.285
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.229
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Fmo2
- Phenotype
Gene ontology
- Biological process
- organic acid metabolic process;NADP metabolic process;xenobiotic metabolic process;toxin metabolic process;drug metabolic process;NADPH oxidation;oxygen metabolic process
- Cellular component
- endoplasmic reticulum membrane;membrane;organelle membrane
- Molecular function
- monooxygenase activity;N,N-dimethylaniline monooxygenase activity;flavin adenine dinucleotide binding;NADP binding